FGF-21 as a novel metabolic regulator. - Wikidata - awgldk - TriplyDB

FGF-21 as a novel metabolic regulator.

FGF-21 as a novel metabolic regulator.

http://www.wikidata.org/entity/Q24523933

about

Circulating fibroblast growth factor 21 levels are closely associated with hepatic fat content: a cross-sectional study Molecular functions of thyroid hormones and their clinical significance in liver-related diseases betaKlotho is required for fibroblast growth factor (FGF) 21 signaling through FGF receptor (FGFR) 1c and FGFR3c Fibroblast growth factor-21 (FGF21) regulates low-density lipoprotein receptor (LDLR) levels in cells via the E3-ubiquitin ligase Mylip/Idol and the Canopy2 (Cnpy2)/Mylip-interacting saposin-like protein (Msap)Discovery of a cytokine and its receptor by functional screening of the extracellular proteome C-terminal tail of FGF19 determines its specificity toward Klotho co-receptors Tissue-specific expression of betaKlotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21 Liver-specific activities of FGF19 require Klotho beta FGF21 N- and C-termini play different roles in receptor interaction and activation Fibroblast growth factor 21 regulates energy metabolism by activating the AMPK-SIRT1-PGC-1alpha pathway Obesity is a fibroblast growth factor 21 (FGF21)-resistant state Endocrine fibroblast growth factors 15/19 and 21: from feast to famine Integrated regulation of hepatic metabolism by fibroblast growth factor 21 (FGF21) in vivo Major urinary protein-1 increases energy expenditure and improves glucose intolerance through enhancing mitochondrial function in skeletal muscle of diabetic mice FGF21 induces PGC-1alpha and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response Klotho and aging Identification of MUP1 as a regulator for glucose and lipid metabolism in mice Fibroblast growth factor 21: from pharmacology to physiology Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family BetaKlotho is required for metabolic activity of fibroblast growth factor 21 Molecular insights into the klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members Novel Molecules Regulating Energy Homeostasis: Physiology and Regulation by Macronutrient Intake and Weight Loss Physiological and Pharmacological Roles of FGF21 in Cardiovascular Diseases Implication of hepatokines in metabolic disorders and cardiovascular diseases Non-sympathetic control of brown adipose tissue Type 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection--Liver: The "Musketeer" in the Spotlight The FGF21-adiponectin axis in controlling energy and vascular homeostasis Fibroblast Growth Factor 21 Protects against Atherosclerosis via Fine-Tuning the Multiorgan Crosstalk Fibroblast Growth Factor Signaling in Metabolic Regulation Metabolic Effects of FGF-21: Thermoregulation and Beyond Research Perspectives on the Regulation and Physiological Functions of FGF21 and its Association with NAFLD Endocrine FGFs: Evolution, Physiology, Pathophysiology, and Pharmacotherapy FGF21 and Cardiac Physiopathology Skeletal muscle as an endocrine organ: PGC-1α, myokines and exercise FGF21, energy expenditure and weight loss - How much brown fat do you need?Inventing new medicines: The FGF21 story Anorexia nervosa and bone metabolism The brain and brown fat Stressed Liver and Muscle Call on Adipocytes with FGF21 Transcriptional regulation of fibroblast growth factor 21 expression

P2860

Q21135215-8B4F7BEA-7FB0-43B7-8010-DBEED6A3CAB2 Q21284820-2CFF381B-FD1B-411B-92CF-47384F934E96 Q24306279-E50E4D4D-9654-4CB3-AA1B-03737431ABE1 Q24306597-3F0E91FD-E555-4B3A-8FB2-842B9644247E Q24310846-66E8E7C3-2236-45DF-AFF8-662E5359ECE1 Q24317949-C2D9FB90-B79F-4B74-975A-F93E8B98A32B Q24318639-B59F61F8-A608-4C99-B25B-62BCB43F59F1 Q24319088-4618A8F5-4ED7-4EA1-BC45-3728A7D2D237 Q24322074-6B9D1BCB-C1AA-406F-8820-97BC299490A6 Q24607012-487AA5C2-C4EA-45C5-87E5-5EEE4E53ADB1 Q24625976-19153E5A-E2A0-4F4E-B87E-59B7373BB89F Q24629260-2AE4C9FC-30CE-439C-A591-A314479489B4 Q24632545-F73A7058-426B-4159-A7D4-893CAA2BCDFC Q24642546-3E9F7285-3DD7-45B4-A5D1-31A9F028F8A0 Q24653481-2116010D-6BA7-441C-903B-91077D5FBC1A Q24654902-A1D71808-4C22-496C-9A6E-6E8343B8DE3B Q24657939-3255FC76-7A86-4454-822D-026539C84875 Q24658126-79B8DFBC-A580-4174-9AC7-F80B8756D307 Q24676527-CD7296A3-164E-4940-9290-8D7F46C583B0 Q24681531-D58C6164-9CAA-4569-8CF8-819520375F82 Q24683254-F8BB6E88-AD21-4D07-AE76-120D67A61CEF Q26741066-07352E57-7262-4C56-83E7-660DD42FF1B2 Q26744232-BC1925D6-AD8C-4840-8005-B171AB688058 Q26751147-DB472325-B6EC-4F97-B956-5CB8DA79C59A Q26751836-097D509B-FEC8-4296-8021-CE97E7B29280 Q26752583-F89F2AB4-DF42-41C0-B9A4-68CC5A85CDCE Q26753369-FF60C605-3037-4AE8-A01F-43FC01CE5E89 Q26766528-927F1775-E926-4854-9CF2-B53AB07763D8 Q26772751-9CC13ABF-C301-4CC0-9B5F-3ECA40B3744E Q26781427-02B92FDC-B1AD-401F-848C-75876EEA4311 Q26781431-074BDCE4-40A8-498A-A007-AB937FE526C0 Q26781556-7580B91E-9E56-427A-9C18-3D7E5FCA9AFF Q26784524-6050E27F-A76E-4D55-A528-0B082ADCB0B3 Q26785313-C957C609-963D-48BE-A7E4-4ECBA9561E29 Q26785678-20AB40A3-53DF-4D91-B736-A4084C16BB67 Q26823319-6A9D6BC5-34FF-4036-9265-6867B3A330A8 Q26829507-18215BFE-8917-447D-ADEE-324833A5B1AC Q26865368-67CBF811-F1C4-4780-8B9E-6FD72C23D648 Q27014973-E9E0531F-DA9A-414D-BD9D-6317B5FFEC15 Q27024818-CC6D5EA2-5E49-49AE-9DFE-044173A3CCE9

P2860

FGF-21 as a novel metabolic regulator.

http://www.wikidata.org/entity/Q24523933

description

2005 nî lūn-bûn

@nan

2005 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

FGF-21 as a novel metabolic regulator

@nl

FGF-21 as a novel metabolic regulator.

@ast

FGF-21 as a novel metabolic regulator.

@en

FGF-21 as a novel metabolic regulator.

@en-gb

type

label

FGF-21 as a novel metabolic regulator

@nl

FGF-21 as a novel metabolic regulator.

@ast

FGF-21 as a novel metabolic regulator.

@en

FGF-21 as a novel metabolic regulator.

@en-gb

prefLabel

FGF-21 as a novel metabolic regulator

@nl

FGF-21 as a novel metabolic regulator.

@ast

FGF-21 as a novel metabolic regulator.

@en

FGF-21 as a novel metabolic regulator.

@en-gb

P1433

Q24523933-904A74DA-8F96-4446-8DB5-13CE6235888A

P1476

Q24523933-1043D0D6-78A1-4201-BF9B-EFBAF601EE00

P2093

Q24523933-17A9B53E-8DED-4A15-9EE4-86EEC92ED77E

Q24523933-1AA2EF5E-4B2F-4BE2-998A-E57E51A76FDF

Q24523933-232A5761-2988-4B07-854C-B0532CE26AAE

Q24523933-253BA468-2CD2-45BE-B17E-22A1F35E2598

Q24523933-30C4A5FA-DE0E-4793-9015-CCDA984E1A72

Q24523933-385F8EF0-1F59-4C7A-930F-EA7F47D5F566

Q24523933-4BC82AC9-6E10-43B5-8350-2A2DA4127651

Q24523933-55856BBB-137C-424D-8606-6ACF6EDAFC05

Q24523933-A2338435-CD89-4C40-8A43-8D8A2874F775

Q24523933-A7D5C967-E996-4D88-A67D-4D9F617BF9D3

P2860

Q24523933-008109AF-1845-4C85-8CAA-22F97247628C

Q24523933-02918F40-A1F5-43F7-BEAD-84A892E7886D

Q24523933-126D5BD4-7709-4F95-9CA0-EFCB5E9D11CA

Q24523933-149EB192-E6AC-456C-86DE-1EE55A145A09

Q24523933-1A2DF664-581E-4674-9C68-B814CC7F670A

Q24523933-25C9D327-E542-4D30-9A24-CAF1C6B25F64

Q24523933-39A292FA-F527-4A3C-84DE-81EE08253D3A

Q24523933-43E97040-3060-4126-9185-F29FDC628115

Q24523933-4C0B2D02-D2AD-4CF4-B807-A25093B31196

Q24523933-56257090-07D3-4BC5-BF03-706614646A03

P304

Q24523933-3287716B-AD52-495E-9204-BE6807BE1166

P31

Q24523933-6E6C48B4-22B2-442F-8784-0B780F487F3E

P3181

Q24523933-3C419818-EAE7-425C-81CE-FA89D84A1251

P356

Q24523933-AADE567C-03F6-48F3-A650-82C542457A08

P407

Q24523933-DE9DA74F-DF6E-44A4-A889-92D8F29868B5

P433

Q24523933-F006090B-4F49-49A9-AC56-0FA9F947889E

P478

Q24523933-07825369-E901-4057-8868-B0C232F1359D

P577

Q24523933-2A42B913-D12D-48D1-94BB-FDB410BF2A06

P698

Q24523933-B6AD4158-324B-4962-BB87-6DD0DD0E5ACA

P932

Q24523933-5F664252-DE86-47E5-82E9-A8FD06014433

P3181

P356

P1433

Journal of Clinical Investigation

P1476

FGF-21 as a novel metabolic regulator.

@en

P2093

Alexei Kharitonenkov

http://www.w3.org/2001/XMLSchema#string

Amy M Ford

http://www.w3.org/2001/XMLSchema#string

Anja Koester

http://www.w3.org/2001/XMLSchema#string

Armen B Shanafelt

http://www.w3.org/2001/XMLSchema#string

De-Shan Li

http://www.w3.org/2001/XMLSchema#string

Elizabeth J Galbreath

http://www.w3.org/2001/XMLSchema#string

Eric D Hawkins

http://www.w3.org/2001/XMLSchema#string

Farrokh Mehrbod

http://www.w3.org/2001/XMLSchema#string

George E Sandusky

http://www.w3.org/2001/XMLSchema#string

Jesper Gromada

http://www.w3.org/2001/XMLSchema#string

P2860

Structure and expression of a novel human FGF, FGF-19, expressed in the fetal brain

FGF-19, a novel fibroblast growth factor with unique specificity for FGFR4

Identification of a novel FGF, FGF-21, preferentially expressed in the liver

A family of proteins that inhibit signalling through tyrosine kinase receptors

Fibroblast growth factors

A mouse model of hepatocellular carcinoma: ectopic expression of fibroblast growth factor 19 in skeletal muscle of transgenic mice

Cell signaling by receptor tyrosine kinases

Fibroblast growth factors, their receptors and signaling

Identification of a new fibroblast growth factor receptor, FGFR5

New perspectives into the molecular pathogenesis and treatment of type 2 diabetes

P304

1627-1635

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

373134

http://www.w3.org/2001/XMLSchema#string

P356

10.1172/JCI23606

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

115

http://www.w3.org/2001/XMLSchema#string

P577

2005-05-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15902306

http://www.w3.org/2001/XMLSchema#string

P932

1088017

http://www.w3.org/2001/XMLSchema#string